• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Medical Device Problem Codes Material Split, Cut or Torn (4008); Device Stenosis (4066)
Health Effect - Clinical Codes Heart Failure/Congestive Heart Failure (4446); Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 10/02/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2014, a 23mm trifecta valve was implanted.On an unknown date, stenosis, leaflet tear, and regurgitation were observed on echocardiography; the patient had associated symptoms of heart failure.On (b)(6) 2025, a 23mm navitor valve was implanted via valve-in-valve with good results.The patient was reported to be in stable condition.
 
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
Explant approximately 11 years and 7 months post-implant due to heart failure symptoms, stenosis, leaflet tear, and regurgitation was reported.A more comprehensive assessment, including histopathological examination of the valve tissue, could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incidents could not be conclusively determined.The reported hospitalization and surgical intervention were results of case-specific circumstances as the patient was admitted and a valve was implanted (valve-in-valve).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23372505
Report Number2135147-2025-06048
Device Sequence Number18371690
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public(01)05414734052030(17)160607
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/07/2016
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number4673094
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/02/2025
Supplement Date Received by Manufacturer12/13/2025
Initial Report FDA Received Date10/23/2025
Supplement Report FDA Received Date12/17/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/09/2014
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age77 YR
Patient SexMale
-
-